News Imbruvica granted fourth Breakthrough status The drug is also granted Orphan Drug Designation by the FDA.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face